Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome

BACKGROUND: Beta(1)-receptor antagonists (BBs) are commonly administered in the treatment of cardiovascular disease (CVD). The reported benefits of BB use in CVD patients with concomitant obstructive sleep apnea (OSA) may be limited by their impact on apnea-induced bradycardias. Therefore the aim of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cardiol
Autori principali: WOLF, Jacek, DROZDOWSKI, Jacek, CZECHOWICZ, Krzysztof, WINKLEWSKI, Paweł J., JASSEM, Ewa, KARA, Tomas, SOMERS, Virend K., NARKIEWICZ, Krzysztof
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656106/
https://ncbi.nlm.nih.gov/pubmed/26386925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2015.08.139
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi